A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels.

MLA

Svensson, Maria K., et al. “A Retrospective Nationwide Analysis of Evolocumab Use in Sweden and Its Effect on Low-Density Lipoprotein Cholesterol Levels.” Upsala Journal of Medical Sciences, vol. 129, Jan. 2024. EBSCOhost, https://doi.org/10.48101/ujms.v129.9618.

APA

Svensson, M. K., James, S., Ravn-Fischer, A., Villa, G., Schalin, L., Cars, T., Gustafsson, S., & Hagström, E. (2024). A retrospective nationwide analysis of evolocumab use in Sweden and its effect on low-density lipoprotein cholesterol levels. Upsala Journal of Medical Sciences, 129. https://doi.org/10.48101/ujms.v129.9618

Chicago

Svensson, Maria K, Stefan James, Annica Ravn-Fischer, Guillermo Villa, Lovisa Schalin, Thomas Cars, Stefan Gustafsson, and Emil Hagström. 2024. “A Retrospective Nationwide Analysis of Evolocumab Use in Sweden and Its Effect on Low-Density Lipoprotein Cholesterol Levels.” Upsala Journal of Medical Sciences 129 (January). doi:10.48101/ujms.v129.9618.